Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wierda

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Journal of Clinical Anesthesia|July 1, 1994
Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokineticsL van den Broek, J M Wierda, N J Smeulers, et al.
Therapeutic Drug Monitoring|February 1, 1993
Pharmacokinetics of cyclosporine A after intravenous and oral administration in liver transplant patients measured with high-performance liquid chromatographyI J Klompmaker, J M Wierda, W J Sluiter, et al.
European Journal of Anaesthesiology|November 1, 1991
The pharmacokinetics, urinary and biliary excretion of pipecuronium bromideJ M Wierda, J Szenohradszky, A P De Wit, et al.
British Journal of Anaesthesia|February 1, 1989
Haemodynamic effects of vecuroniumJ M Wierda, E Maestrone, A F Bencini, et al.
Anaesthesia|August 25, 1999
The use of neuromuscular blocking agents in noncardiac surgery after dynamic cardiomyoplastyJ Timmerman, J M Van Der Maaten, J M Wierda, et al.
Journal of Virology|July 1, 1997
Hemagglutinin-esterase, a novel structural protein of torovirusL A Cornelissen, C M Wierda, F J van der Meer, et al.
British Journal of Anaesthesia|November 30, 2000
Rapacuronium 2.0 or 2.5 mg kg-1 for rapid-sequence induction: comparison with succinylcholine 1.0 mg kg-1M Blobner, R K Mirakhur, J M Wierda, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Journal of Clinical Anesthesia|July 1, 1994
Clinical pharmacology of rocuronium (Org 9426): study of the time course of action, dose requirement, reversibility, and pharmacokineticsL van den Broek, J M Wierda, N J Smeulers, et al.
Therapeutic Drug Monitoring|February 1, 1993
Pharmacokinetics of cyclosporine A after intravenous and oral administration in liver transplant patients measured with high-performance liquid chromatographyI J Klompmaker, J M Wierda, W J Sluiter, et al.
European Journal of Anaesthesiology|November 1, 1991
The pharmacokinetics, urinary and biliary excretion of pipecuronium bromideJ M Wierda, J Szenohradszky, A P De Wit, et al.
British Journal of Anaesthesia|February 1, 1989
Haemodynamic effects of vecuroniumJ M Wierda, E Maestrone, A F Bencini, et al.
Anaesthesia|August 25, 1999
The use of neuromuscular blocking agents in noncardiac surgery after dynamic cardiomyoplastyJ Timmerman, J M Van Der Maaten, J M Wierda, et al.
Journal of Virology|July 1, 1997
Hemagglutinin-esterase, a novel structural protein of torovirusL A Cornelissen, C M Wierda, F J van der Meer, et al.
British Journal of Anaesthesia|November 30, 2000
Rapacuronium 2.0 or 2.5 mg kg-1 for rapid-sequence induction: comparison with succinylcholine 1.0 mg kg-1M Blobner, R K Mirakhur, J M Wierda, et al.
Pageof 9